Evidence map›Paper›PMID 35679294›Full record

SynthesisResearch synthesis methods2022

Assessment of key characteristics, methodology, and effect size measures used in meta-analysis of human-health-related animal studies.

Carlijn R Hooijmans, Rogier Donders, Kristen Magnuson, Kimberley E Wever, Mehmet Ergün, Andrew A Rooney, Vickie Walker, Miranda W Langendam

Abstract readMeta-Analysis
In one paragraph

Synthesis in Research synthesis methods, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Modular (universal) CAR-T platformsFrontiers in immunology · 2024
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Developing a database of systematic reviews of animal studies.Regulatory toxicology and pharmacology : RTP · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Carlijn R HooijmansDepartment of Anesthesiology, pain and palliative care, Radboud university medical center, Nijmegen, The Netherlands.ORCID https://orcid.org/0000-0001-6435-5714
Rogier DondersBiostatistics, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherlands.
Kristen MagnusonICF, Fairfax, Virginia, USA.
Kimberley E WeverDepartment of Anesthesiology, pain and palliative care, Radboud university medical center, Nijmegen, The Netherlands.
Mehmet ErgünSystematic Review Centre for Laboratory animal Experimentation (SYRCLE), Department for Health Evidence, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherlands.
Andrew A RooneyDivision of the National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, North Carolina, USA.
Vickie WalkerDivision of the National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, North Carolina, USA.
Miranda W LangendamDepartment of Epidemiology and Data Science, Amsterdam UMC location Academic Medical Centre, Amsterdam, The Netherlands.

Funding

Scientific Cyberinfrastructure Research ProgramZIAES103385 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI WALKER, VICKIE · 2022 to 2025
$17.4M
NIEHS NIH HHS HHSN273201600015CNIH HHS GS00Q14OADU417NIH HHS HHSN273201600015U
6 · The paper itself

Abstract

Since the early 1990s the number of systematic reviews (SR) of animal studies has steadily increased. There is, however, little guidance on when and how to conduct a meta-analysis of human-health-related animal studies. To gain insight about the methods that are currently used we created an overview of the key characteristics of published meta-analyses of animal studies, with a focus on the choice of effect size measures. An additional goal was to learn about the rationale behind the meta-analysis methods used by the review authors. We show that important details of the meta-analyses are not fully described, only a fraction of all human-health-related meta-analyses provided rationales for their decision to use specific effect size measures. In addition, our data may suggest that authors make post-hoc decisions to switch to another effect size measure during the course of their meta-analysis, and possibly search for significant effects. Based on analyses in this paper we recommend that review teams: 1) publish a review protocol before starting the conduct of a SR, prespecifying all methodological details (providing special attention to the planned meta-analysis including the effect size measure and the rational behind choosing a specific effect size, prespecifying subgroups and restricting the number of subgroup analyses), 2) always use the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) checklist to report your SR of animal studies, and 3) use the random effects model (REM) in human-health-related meta-analysis of animal studies, unless the assumptions for using the fixed effect model (FEM) are all met.

Indexed as

ChecklistResearch ReportAnimalsHumansResearch Designeffect size measuresmeta-analysismeta-researchsystematic review of animal studies

Identifiers

PMID35679294
PMCPMC9796290

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.